Chang et al., 2017 - Google Patents
Erythrocyte-derived microparticles activate pulmonary endothelial cells in a murine model of transfusionChang et al., 2017
View PDF- Document ID
- 2417021290257381568
- Author
- Chang A
- Kim Y
- Seitz A
- Schuster R
- Lentsch A
- Pritts T
- Publication year
- Publication venue
- Shock
External Links
Snippet
Erythrocyte-derived microparticles (MPs) are sub-micrometer, biologically active vesicles shed by red blood cells as part of the biochemical changes that occur during storage. We hypothesized that MPs from stored red blood cells would activate endothelial cells. MPs from …
- 239000011859 microparticle 0 title abstract description 77
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chang et al. | Erythrocyte-derived microparticles activate pulmonary endothelial cells in a murine model of transfusion | |
| Youssef et al. | Transfusion-related immunomodulation: a reappraisal | |
| Marcoux et al. | Platelet‐derived extracellular vesicles convey mitochondrial DAMPs in platelet concentrates and their levels are associated with adverse reactions | |
| Muszynski et al. | Transfusion‐related immunomodulation: review of the literature and implications for pediatric critical illness | |
| Fischer et al. | Microparticles from stored red blood cells enhance procoagulant and proinflammatory activity | |
| Khan et al. | Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury | |
| Kim et al. | Microparticles from aged packed red blood cell units stimulate pulmonary microthrombus formation via P-selectin | |
| McMichael et al. | Effect of leukoreduction on transfusion-induced inflammation in dogs | |
| Radwanski et al. | The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response | |
| Zimring | Fresh versus old blood: are there differences and do they matter? | |
| L'Acqua et al. | Red blood cell transfusion is associated with increased hemolysis and an acute phase response in a subset of critically ill children | |
| Xie et al. | Platelet‐derived microparticles induce polymorphonuclear leukocyte‐mediated damage of human pulmonary microvascular endothelial cells | |
| Phillips et al. | A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation | |
| Wang et al. | Adverse transfusion reactions and what we can do | |
| Cunin et al. | Megakaryocytes compensate for Kit insufficiency in murine arthritis | |
| Palumbo et al. | Bruton tyrosine kinase inhibition attenuates liver damage in a mouse warm ischemia and reperfusion model | |
| Xie et al. | Microparticles in red cell concentrates prime polymorphonuclear neutrophils and cause acute lung injury in a two-event mouse model | |
| West et al. | Transfusion-related acute lung injury: advances in understanding the role of proinflammatory mediators in its genesis | |
| Wojczyk et al. | Macrophages clear refrigerator storage–damaged red blood cells and subsequently secrete cytokines in vivo, but not in vitro, in a murine model | |
| Kuebler et al. | Extracellular vesicles: effectors of transfusion-related acute lung injury | |
| Miyamoto et al. | Association of local intrapulmonary production of antibodies specific to donor major histocompatibility complex class I with the progression of chronic rejection of lung allografts | |
| Day et al. | Preactivated and disaggregated shape-changed platelets protected against acute respiratory distress syndrome complicated by sepsis through inflammation suppression | |
| Noubouossie et al. | Red cell extracellular vesicles and coagulation activation pathways | |
| Thuer et al. | Total platelet donation count and donation frequency are determinants of plateletpheresis‐associated lymphopenia | |
| Almizraq et al. | Platelet vesicles are potent inflammatory mediators in red blood cell products and washing reduces the inflammatory phenotype |